Prostate specific antigen (PSA) testing for the diagnosis of prostate cancer (PCa) results in a high false-positive rate, mostly due to the detection of elevated PSA levels in the blood when there is a benign disease such as enlargement or inflammation of the prostate [1]. This evidence concerns the gene KLK3 and prostate cancer.